P

PAVmed
D

PAVM

0.66510
USD
-0.02
(-3.61%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
0
Market Cap
11,502,651
Related Instruments
ABT
ABT
-0.770
(-0.56%)
135.620 USD
BSX
BSX
1.190
(1.21%)
99.750 USD
EW
EW
-0.720
(-0.95%)
75.170 USD
I
IRTC
-1.580
(-1.09%)
143.900 USD
ISRG
ISRG
-0.86
(-0.17%)
511.99 USD
JNJ
JNJ
0.425
(0.27%)
157.090 USD
MDT
MDT
-1.240
(-1.40%)
87.270 USD
M
MMSI
-0.660
(-0.71%)
92.880 USD
T
TNDM
-0.165
(-0.79%)
20.760 USD
ZBH
ZBH
-1.940
(-2.08%)
91.260 USD
More
News

Title: PAVmed

Sector: Healthcare
Industry: Medical Devices
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.